Top News
 |
Ranbaxy to develop anti-infective drugs for Merck May 12, 2008
LONDON/MUMBAI (Reuters) - India's Ranbaxy Laboratories Ltd is to develop new anti-infective drugs for Merck & Co Inc, underlining the growing use of Indian pharmaceutical research by multinational companies. |
|
Forest ends promotion of Daiichi hypertension drug May 12, 2008
NEW YORK (Reuters) - Forest Laboratories Inc has ended its agreement with Daiichi Sankyo Co Ltd to co-promote Daiichi's blood-pressure drug Azor, as Forest shifts resources to support other products, the companies said on Monday. |
|
DITEC to Hold its 2K8 Conference May 12, 2008
DITEC will once again present its DITEC 2K8 Continuing Education Conference & National Vendor Exhibit from May 21 through May 23 in Cleveland.
|
|
EARNINGS POLL-Solvay Q1 profit down on dollar, input costs May 9, 2008
BRUSSELS (Reuters) - Belgian drugs, chemicals and plastics maker Solvay will report a 9 percent fall in first-quarter operating profit on Tuesday due to the weak dollar, commodity price spikes and a depressed building sector. |
|
Sanofi hit by generic Plavix threat in Europe May 9, 2008
LONDON (Reuters) - French drugmaker Sanofi-Aventis, which briefly encountered generic competition to its second-biggest product Plavix in the United States in 2006 and 2007, now faces a similar threat in Europe. |
|
Mylan posts bigger loss after charges; shares fall May 9, 2008
NEW YORK (Reuters) - Drugmaker Mylan Inc on Thursday reported a wider first-quarter loss due to lower U.S. sales of generic medicines and special charges, although overall revenue more than doubled after a recent acquisition. |
|
Hungary's Richter lowers sales outlook after Q1 May 9, 2008
BUDAPEST (Reuters) - Hungarian drug maker Richter Gedeon delivered first-quarter operating figures in line with market expectations on Friday but lowered its sales outlook for some key markets, including the U.S. and Hungary. |
|
Schweizerhall plans German generic Plavix launch May 9, 2008
LONDON (Reuters) - Schweizerhall, a generic drug company based in Basel, said on Friday it was close to winning approval for a generic version of Sanofi-Aventis's blockbuster blood thinning drug Plavix in Germany. |
|
Takeda sees big profit slump on Millennium costs May 9, 2008
TOKYO (Reuters) - Japan's Takeda Pharmaceutical Co Ltd posted a 7.7 percent fall in annual operating profit on Friday and forecast a sharp drop for the current year on costs for its $8.8 billion purchase of U.S. biotech firm Millennium Pharmaceuticals. |
|
Osiris to sell unit to NuVasive for up to $85 mln May 9, 2008
BANGALORE (Reuters) - Osiris Therapeutics Inc said it agreed to sell its Osteocel business to medical device maker NuVasive Inc for $85 million, including potential milestone payments, sending its shares up 15 percent. NuVasive will buy the business for $35 million in cash, and additional milestone-based payments of up to $50 million in either cash or a combination of cash and stock. |
|
Alabama Biomeds Launch New Group May 9, 2008
Biomeds have organized to form the new Alabama Biomedical Society, which will hold its kickoff meeting on Saturday, May 17 in Birmingham, Ala. |
|
Barr Pharma profit disappoints, shares down 23 pct May 8, 2008
NEW YORK (Reuters) - Barr Pharmaceuticals Inc reported disappointing first-quarter profit on weak U.S. sales and slashed its full-year forecast on Thursday, driving its shares down 23 percent to their lowest levels since late 2004. |
|
Stryker to raise spending on quality, compliance May 8, 2008
CHICAGO (Reuters) - Stryker Corp said on Thursday it plans to spend $50 million in 2008 to improve its quality and compliance as it works to resolve issues with federal health regulators. |
|
Biovail to shift focus, shut plants as profit dips May 8, 2008
TORONTO (Reuters) - Biovail Corp said on Thursday that it will close operations in Puerto Rico, resulting in charges of $80 million to $100 million in the next few quarters, as it shifts focus to a new line of drugs. |
|
 |
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
|   |
|
|
|
 |
|
Resources
